Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alimera Sciences Inc (ALIM)

Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alimera Sciences: Q4 Earnings Snapshot

Alimera Sciences: Q4 Earnings Snapshot

ALIM : 3.90 (unch)
Alimera Sciences: Q3 Earnings Snapshot

Alimera Sciences: Q3 Earnings Snapshot

ALIM : 3.90 (unch)
Alimera Sciences: Q2 Earnings Snapshot

Alimera Sciences: Q2 Earnings Snapshot

ALIM : 3.90 (unch)
Alimera Sciences: Q1 Earnings Snapshot

Alimera Sciences: Q1 Earnings Snapshot

ALIM : 3.90 (unch)
ChromaDex (CDXC) Reports Q1 Loss, Tops Revenue Estimates

ChromaDex (CDXC) delivered earnings and revenue surprises of 40% and 16.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CDXC : 3.48 (-5.18%)
ALIM : 3.90 (unch)
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates

ADC Therapeutics SA (ADCT) delivered earnings and revenue surprises of 7.50% and 5.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ADCT : 4.49 (+6.90%)
ALIM : 3.90 (unch)
Will Alimera Sciences (ALIM) Report Negative Q1 Earnings? What You Should Know

Alimera Sciences (ALIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ALIM : 3.90 (unch)
CDXS : 3.49 (-0.57%)
Alimera Sciences (ALIM) Reports Q4 Loss, Misses Revenue Estimates

Alimera Sciences (ALIM) delivered earnings and revenue surprises of -92.86% and 11.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ALIM : 3.90 (unch)
AMGN : 284.32 (-0.69%)
Alimera Sciences: Q4 Earnings Snapshot

Alimera Sciences: Q4 Earnings Snapshot

ALIM : 3.90 (unch)
Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates

Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 7.69% and 73.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SYBX : 1.7900 (+0.56%)
ALIM : 3.90 (unch)

Barchart Exclusives

Ford Motor vs. Toyota: Which Hybrid EV Stock Is a Better Buy?
With hybrid EVs gaining popularity, let’s find out whether shares of Ford or Toyota are a better buy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar